[ORGANIZATION]
Halozyme Therapeutics
Featured in 2 tracked stories · first seen
Situations
Halozyme Therapeutics market performance
2 clusters · 4 sources · last updated
Latest: Halozyme Therapeutics shares reach new 52-week high
Halozyme Therapeutics reached a new 52-week high, with share prices hitting $109.10 and a market capitalization of $12.33 billion. Financial analysts have responded with mixed but generally positive ratings. Leerink Pa
Biotechnology sector market trends
2 clusters · 3 sources · last updated
Latest: Biotech sector sees momentum through clinical trials and M&A
The biotechnology sector has demonstrated momentum driven by merger and acquisition activity and positive clinical trial results, including developments regarding a skin cancer vaccine trial. Investment analysts have no